Company / Operating Margin
Bionano Genomics, Inc. Operating Margin History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-117.0%
FY2025
5-year range
-596.0% / -117.0%
FY2021-FY2025
Trend
+65.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Margin has fluctuated over the past 8 years, ranging from -596.0% in FY2023 to -117.0% in FY2025.
Based on SEC 10-K filings.
-117.0% in FY2025 with a 5-year CAGR of +336.4%.
Improved from -596.0% to -117.0% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- +356.8pp
- 5-Year Change
- +336.4pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, operating margin increased 65.4% year-over-year.
- Lowest operating margin in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -8.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -117.0% | +65.4% |
| FY2024 | -337.9% | +43.3% |
| FY2023 | -596.0% | -25.8% |
| FY2022 | -473.7% | -10.5% |
| FY2021 | -428.8% | +5.4% |
| FY2020 | -453.4% | -77.5% |
| FY2019 | -255.4% | -50.2% |
| FY2018 | -170.1% | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 22, 2026